Abstract:Interferon-alpha (IFN) has a short circulating half-life, which not only leads to limited clinical efficacy, but also causes severe side effects and poor patient compliance. Previously, we developed ELPfusion and site-specific in situ growth (SIG) methods to prolong the half-life of IFN, while the adopted intravenous administration still could not well concentrate IFN inside tumour tissues. In order to enhance the tumour accumulation and antitumour efficacy of IFN, in this study, we report intratumoural administration of temperature responsive interferon-poly(di(ethylene glycol) methyl ether methacrylate) conjugates (IFN-PDEGMA). First, we employed SIG method to synthesize a series of temperature responsive IFN-PDEGMAs with different molecular weights (10 kDa, 30 kDa, 60 kDa and 100 kDa). The preparation process was monitored by SDS-PAGE, and the molecular weights, hydrodynamic radius and secondary structures of conjugates were characterized by GPC, DLS and CD (circular dichroism), respectively. The phase transition temperatures were determined to be around 22 degrees C. Thus, IFN-PDEGMA were soluble below 22 degrees C; and they became insoluble above 22 degrees C. Since the body temperature of mice is above 22 degrees C, IFN-PDEGMA injected into the tumour tissue of mice aggregated locally and became a drug depot in the tumour. In vitro characterization demonstrated that the structure and anti-proliferative activity of IFN were well remained for IFN-PDEGMA. In vivo experiments showed that the survival time of A375 melanoma-bearing mice were well extended by IFN-PDEGMA treatment compared with IFN-alpha. To be specific, the survival times of mice treated by IFN-PDEGMA of 10 kDa, 30 kDa, 60 kDa and 100 kDa were 36.5, 31, 29.5 and 28 days, respectively. IFN-PDEGMA of 10 kDa and 30 kDa both exhibited better anti-melanoma efficacy than commercial long-acting interferon, PEGASYS. Meanwhile, the biological safety experiments also showed that IFN-PDEGMA treatment did not have obvious side effects on normal tissues. In summary, we, for the first time, reported intratumoural administration of temperature responsive IFN-PDEGMA and studied the rule about how the molecular weight impacts on their properties in vitro and in vivo. This study not merely displayed an instance of temperature responsive protein-polymer conjugates and their anti-tumour efficacy, but also provided inspiration to further build a series of smart protein-polymer conjugates and seek for their potential applications in the diagnosis and treatment of major diseases such as cancer, virosis, diabetes and cardiovascular disease.

Preparation of Bioactive Interferon Alpha-Loaded Polysaccharide Nanoparticles Using a New Approach of Temperature-Induced Water Phase/water-Phase Emulsion.

Retracted: Preparation of Bioactive Interferon Alpha-Loaded Polysaccharide Nanoparticles Using A New Approach of Temperature-Induced Water Phase/Water-Phase Emulsion (retracted Article. See Vol. 13, Pg. 2277, 2018)

Hydrophilic Biodegradable Microspheres of Interferon-Alpha and Its Pharmacokinetics in Mice.

Preparation and Characterization of Interferon-Loaded Magnetic Biodegradable Microspheres.

Construction and in Vivo/in Vitro Evaluation of a Nanoporous Ion-Responsive Targeted Drug Delivery System for Recombinant Human Interferon Alpha-2B Delivery

The Preparation and Research of Vitro-release of Interferon-loaded Microspheres

Physiological and Chemical Characteristics of Recombinant Human Interferon Α2b Modified with Polyethylene Glycol

Construction, Expression, Purification and Site-specific PEGylation of Integrated Interferon Mutant Cys72

Oral Pharmacokinetics of a Chitosan-Based Nano- Drug Delivery System of Interferon Alpha

Multilayer Nanocarrier for the Codelivery of Interferons: A Promising Strategy for Biocompatible and Long-Acting Antiviral Treatment

Multivesicular liposome formulations for the sustained delivery of interferon α-2b

Multivesicular Liposome Formulations For The Sustained Delivery Of Interferon Alpha-2b

Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.

Temperature-responsive Polymer Conjugation of Interferon-alpha Enhances Antitumor Efficacy

Long-acting interferon-alpha 2a modified with a trimer-structured polyethylene glycol: preparation, in vitro bioactivity, in vivo stability and pharmacokinetics

Polymerization Induced Self-Assembly of a Site-Specific Interferon Α-Block Copolymer Conjugate into Micelles with Remarkably Enhanced Pharmacology

Pegylation and Cell Based Bioassay of Human Interferon-Α2b along Its Docking Studies and Effect on Plasma Half-Life.

Quality Control Methods for PEG-IFNα2b

Preparation of Monopegylated Cyanovirin-N's Derivative and Its Anti-Influenza A Virus Bioactivity in Vitro and in Vivo.

Inhibition Activity of Herpes Virus (HSV) Replication by Α-Tif Sirna-Loaded PLGA-TPGS Nanoparticles in Vitro and in Vivo

PEGylation of Human Interferon-Α2b with Modified Amino Acids Increases Circulation Half-Life and Antiproliferative Activity